Beckman Coulter has launched the Kaluza C flow cytometry analysis software, an advanced data analysis system for the clinical laboratory. The new software streamlines clinical quality control (QC) reporting and addresses standardisation issues in flow cytometry. Kaluza C is CE-marked and listed with the US Food and Drug administration (FDA). It builds on the company’s existing Kaluza analysis software, which is already an essential analysis tool for life science researchers.
Kaluza C software improves the visualisation and analysis of rare events. It makes it possible to process large, multicolour files with up to 20 million events, and set the plot resolution according to the gate level. Furthermore, it enables the operator to focus on a limited number of events to preserve the integrity of the scatter plot. Tools such as easy Boolean gate formation and autogating are also incorporated to improve the analysis of complex data sets.
